Artificial organs and bionics are man-made devices that can be implanted or integrated into humans to either replace a natural organ or provide support for the purpose of restoring a specific function or a group of related functions so that the patient may return to normal life as soon as possible.
North America accounted for the largest share of the global artificial organs & bionic implants market and is expected to maintain its position in the coming years as well.
Market Analysis and Insights: Global Artificial Organs & Bionic Implants Market
In 2020, the global Artificial Organs & Bionic Implants market size was US$ 50840 million and it is expected to reach US$ 81230 million by the end of 2027, with a CAGR of 6.5% between 2021 and 2027
Global Artificial Organs & Bionic Implants Scope and Market Size
The global Artificial Organs & Bionic Implants market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Organs & Bionic Implants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
Segment by Type
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Others
Segment by Application
Hospitals
Clinical Research Institutions
Others
By Company
Medtronic
Boston Scientific
Roche
Zimmer Biomet
Asahi Kasei Medical
Baxter International
Abiomed
Berlin Heart
Thoratec
Gambro AB
Jarvik Heart
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
North America accounted for the largest share of the global artificial organs & bionic implants market and is expected to maintain its position in the coming years as well.
Market Analysis and Insights: Global Artificial Organs & Bionic Implants Market
In 2020, the global Artificial Organs & Bionic Implants market size was US$ 50840 million and it is expected to reach US$ 81230 million by the end of 2027, with a CAGR of 6.5% between 2021 and 2027
Global Artificial Organs & Bionic Implants Scope and Market Size
The global Artificial Organs & Bionic Implants market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Organs & Bionic Implants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
Segment by Type
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Others
Segment by Application
Hospitals
Clinical Research Institutions
Others
By Company
Medtronic
Boston Scientific
Roche
Zimmer Biomet
Asahi Kasei Medical
Baxter International
Abiomed
Berlin Heart
Thoratec
Gambro AB
Jarvik Heart
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.